Rituximab, cladribine, and cyclophosphamide (RCC) induction with rituximab maintenance in chronic lymphocytic leukemia: PALG ‐ CLL4 (ML21283) trial

European Journal of Haematology, EarlyView.
Source: European Journal of Haematology - Category: Hematology Source Type: research